Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Reversal by guanethidine of abnormal oral glucose tolerance in thyrotoxicosis.

Reversal by guanethidine of abnormal oral glucose tolerance in thyrotoxicosis. Lancet. 1966 Apr 23; 1(7443):895-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.